Relevant researches have reported that deletion of MAL gene expression was associated with the development and progression of many malignancies in humans, such as cervical cancer, ovarian cancer, oral cancer, laryngeal cancer, breast cancer, esophageal cancer, gastric cancer, bowel cancer, and renal cancer (42–49). The gene discussed is MAL; the disease is ovarian cancer.